These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 20963425)
1. Apoptotic protein expression in favorable-histology Wilms tumor correlates with tumor recurrence. Agarwal S; Iyer VK; Agarwala S; Mathur SR; Aron M; Datta Gupta S; Verma K Pediatr Surg Int; 2011 Mar; 27(3):303-8. PubMed ID: 20963425 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases. Re GG; Hazen-Martin DJ; El Bahtimi R; Brownlee NA; Willingham MC; Garvin AJ Int J Cancer; 1999 Apr; 84(2):192-200. PubMed ID: 10096254 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor. Salama A; Kamel A J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934 [TBL] [Abstract][Full Text] [Related]
4. Clinical and biologic significance of nuclear unrest in Wilms tumor. Hill DA; Shear TD; Liu T; Billups CA; Singh PK; Dome JS Cancer; 2003 May; 97(9):2318-26. PubMed ID: 12712489 [TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma. Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445 [TBL] [Abstract][Full Text] [Related]
6. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance. Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061 [TBL] [Abstract][Full Text] [Related]
7. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor. Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of p53 expression in Wilms' tumor in children. Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734 [TBL] [Abstract][Full Text] [Related]
9. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125 [TBL] [Abstract][Full Text] [Related]
10. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor. Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206 [TBL] [Abstract][Full Text] [Related]
11. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743 [TBL] [Abstract][Full Text] [Related]
12. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner. Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306 [TBL] [Abstract][Full Text] [Related]
13. The apoptosis regulators p53, bax and PUMA: Relationship and impact on outcome in early stage (FIGO I-II) ovarian carcinoma after post-surgical taxane-based treatment. Skírnisdóttir I; Seidal T Oncol Rep; 2012 Mar; 27(3):741-7. PubMed ID: 22159712 [TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM; J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848 [TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein expression, tumor weight, age, and relapse in patients with stage I and II favorable-histology Wilms' tumor. Teixeira RA; Odone-Filho V; de Camargo B; Zerbini MC; Fillipi R; Alencar A; Cristofani L Pediatr Hematol Oncol; 2011 Apr; 28(3):194-202. PubMed ID: 21214406 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia. Cheah PL; Looi LM; Chan LL Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. Tannapfel A; Nüsslein S; Fietkau R; Katalinic A; Köckerling F; Wittekind C Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):585-91. PubMed ID: 9635706 [TBL] [Abstract][Full Text] [Related]
19. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence. Routh JC; Ashley RA; Sebo TJ; Lohse CM; Husmann DA; Kramer SA; Kwon ED J Urol; 2008 May; 179(5):1954-9; discussion 1959-60. PubMed ID: 18355839 [TBL] [Abstract][Full Text] [Related]